Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03382457 · ClinicalTrials.gov registry record · NA
Clinical Study of Edwards Cardioband FIT Valve Repair System
A NA study of Tricuspid Regurgitation, sponsored by Edwards Lifesciences.
- Active
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 9
- Study locations
NCT03382457: Active NA study of Tricuspid Regurgitation, sponsored by Edwards Lifesciences.
NCT03382457 is a NA study of Tricuspid Regurgitation that is active but no longer recruiting, run by Edwards Lifesciences. The registered enrollment target is 75 participants, below the 531-participant average among 17 other Tricuspid Regurgitation trials with a reported enrollment target (86% lower). The trial reports 9 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03382457, a NA study of Tricuspid Regurgitation, is active but no longer recruiting, sponsored by Edwards Lifesciences.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 9
- Study locations
Study Summary
Clinical Study of the Edwards Cardioband FIT Repair System
Primary Outcome
Number and percentage of patients who experienced at least one major adverse event (MAE).
Conditions Studied
Interventions
- DEVICE Transcatheter Tricuspid Valve Repair
Study Locations (9)
Illinois
- Northwestern University - Chicago
Minnesota
- Mayo Clinic - Rochester
New Jersey
- Morristown Medical Center - Morristown
New York
- Columbia University Medical Center /New York Presbyterian Hospital - New York
Oregon
- Oregon Health & Science University - Portland
Pennsylvania
- Lankenau Medical Center - Wynnewood
Texas
- Heart Hospital Baylor Plano - Plano
Utah
- Intermountain Medical Center - Murray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2031-12-31 |
| Phase | NA |
What the registry record for NCT03382457 still lists
NCT03382457 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 531-participant average among 17 other Tricuspid Regurgitation trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Tricuspid Regurgitation appearing as the primary indexed condition, and to 1 intervention - of which Transcatheter Tricuspid Valve Repair is the first listed.
NCT03382457 lists 9 locations in 9 states (Illinois, Minnesota, New Jersey).
Frequently Asked Questions
What is clinical trial NCT03382457 about?
NCT03382457 is a clinical study titled "Clinical Study of Edwards Cardioband FIT Valve Repair System". Clinical Study of the Edwards Cardioband FIT Repair System
What is the current status of trial NCT03382457?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2018-07-01. Estimated completion is 2031-12-31.
What conditions does trial NCT03382457 study?
This clinical trial studies the following conditions: Tricuspid Regurgitation.
What interventions are being tested in trial NCT03382457?
The interventions under investigation include: Transcatheter Tricuspid Valve Repair (DEVICE).
Who is sponsoring clinical trial NCT03382457?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03382457 being conducted?
This trial has 9 study locations across Illinois, Minnesota, New Jersey, New York, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tricuspid Regurgitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03382457's enrollment target sits among peer trials
75 10th of 17 higher than 7 of 17 other Tricuspid Regurgitation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tricuspid Regurgitation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TTVR Early Feasibility Study
RECRUITING · NA
-
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)
RECRUITING · NA
-
Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
RECRUITING · NA
-
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
RECRUITING · NA
-
Trisol System EFS Study
RECRUITING · NA
-
EFS of the DUO System for Tricuspid Regurgitation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI